CRUSADE Score for Post-MI Bleeding Risk

ورودی‌های بالینی بیمار

حداقل ۱۵ — حداکثر ۵۵ • واحد: percentage

حداقل ۵ — حداکثر ۲۰۰ • واحد: mL/min

حداقل ۳۰ — حداکثر ۲۰۰ • واحد: bpm

حداقل ۶۰ — حداکثر ۲۵۰ • واحد: mmHg

پنل نتیجه و تصمیم بالینی
در انتظار ورودی‌ها
crusade score
—points
آماده برای ارزیابی

پارامترهای بالینی بیمار را در فرم روبرو وارد کنید و روی «محاسبه» کلیک نمایید تا نمره، طبقه خطر و اقدامات فوری نمایش داده شوند.

طبقات خطر و بازه‌های امتیاز:
  • Very Low Risk1–20
  • Low Risk21–30
  • Moderate Risk31–40
  • High Risk41–50

Clinical Decision Pathway

Clinical Decision Pathway & Next Steps

Acute Coronary Syndromes & Chest Pain — سندروم‌های حاد کرونری و درد قفسه سینه

Clinical Rationale:

Evaluate acute chest pain with HEART Score and HEART Pathway for early discharge, detect occlusion MI with Sgarbossa and 4-variable anterior STEMI tool, then assess mortality with GRACE and bleeding with CRUSADE.

← Previous Step in PathwayPrior step

GRACE ACS Risk and Mortality Calculator

امتیاز GRACE (ریسک سندروم حاد کرونری)

Review previous tool

Recommended Clinical Next Steps:

  • ASCVD (Atherosclerotic Cardiovascular Disease) 2013 Risk Calculator from AHA/ACC

    محاسبه‌گر ریسک ۱۰ ساله بیماری قلبی-عروقی آترواسکلروتیک (ASCVD)

    Why next: 10-year secondary cardiovascular preventionForward Escalation — Next Clinical Phase
Direct Clinical Answer

The CRUSADE Score for Post-MI Bleeding Risk calculates stratifying cardiovascular risk, predicting thromboembolic events, or guiding therapeutic interventions. Key inputs include baseline hematocrit. Scores guide initiating guideline-directed medical therapy, antithrombotic or anticoagulant regimens, or urgent coronary angiography. This standardized assessment improves clinical decision safety and bedside patient management.

Clinical Guidelines & Evidence

Risk stratifies patients with NSTEMI undergoing anticoagulation to determine their risk of major bleeding during hospitalization

Clinical Indication

The CRUSADE Score for Post-MI Bleeding Risk is indicated for bedside clinical practice to support Risk stratifies patients with NSTEMI undergoing anticoagulation to determine their risk of major bleeding during hospitalization. It assists healthcare providers in standardizing clinical assessment and therapeutic decision-making.

Target Population

Target population comprises Adult patients presenting with suspected or established coronary artery disease, cardiac arrhythmias, congestive heart failure, or valvular heart defects. Clinical application is indicated across Emergency department, cardiac care unit (CCU), cardiac catheterization laboratory, and outpatient cardiology clinics.

Limitations & Contraindications

In hemodynamically unstable cardiogenic shock, cardiac arrest, or refractory acute coronary syndromes, immediate resuscitation and coronary angiography supersede scoring.

Clinical Pearls & Action Plan

Continuous 12-lead ECG monitoring, serial cardiac troponin measurements, and echocardiographic evaluation align with ESC/ACC/AHA clinical practice guidelines.

Formula & Variables:

Sum of weighted points: Hematocrit + Creatinine Clearance + Heart Rate + Sex + CHF Signs + Diabetes + Vascular Disease + Systolic BP

Input Parameters

NameTypeRequiredDescription
baseline_hematocritfloatYesBaseline hematocrit percentage on admission(percentage)
creatinine_clearancefloatYesCalculated creatinine clearance using Cockcroft-Gault equation(mL/min)
heart_rateintegerYesHeart rate on admission in beats per minute(bpm)
patient_sexstringYesPatient biological sex (female patients have higher bleeding risk)(sex)
signs_chfstringYesSigns of congestive heart failure at presentation (dyspnea, rales, elevated JVP, S3 gallop)(presence)
diabetes_mellitusstringYesHistory of diabetes mellitus (Type 1 or Type 2)(presence)
prior_vascular_diseasestringYesHistory of prior vascular disease (PAD, cerebrovascular disease, aortic aneurysm)(presence)
systolic_blood_pressureintegerYesSystolic blood pressure on admission in mmHg(mmHg)

Score Interpretation & Guidance

RangeStageDescription
1–20Very Low RiskVery low bleeding risk
21–30Low RiskLow bleeding risk
31–40Moderate RiskModerate bleeding risk
41–50High RiskHigh bleeding risk
51–100Very High RiskVery high bleeding risk

Evidence-Based References (EBM)

  • Subherwal S, Bach RG, Chen AY, et al. Baseline risk of major bleeding in non-ST-segment-elevation myocardial infarction: the CRUSADE (Can Rapid risk stratification of Unstable angina patients Suppress ADverse outcomes with Early implementation of the ACC/AHA Guidelines) Bleeding Score. Circulation. 2009;119(14):1873-1882.
  • Abu-Assi E, Raposeiras-Roubin S, Lear P, et al. The risk of bleeding according to the CRUSADE, ACUITY and HAS-BLED scores in acute coronary syndrome patients treated with prasugrel: insights from a four-year registry. Thromb Res. 2013;132(6):652-658.
  • Ariza-Solé A, Sánchez-Elvira G, Sánchez-Salado JC, et al. CRUSADE bleeding score validation for ST-segment-elevation myocardial infarction undergoing primary percutaneous coronary intervention. Thromb Res. 2013;132(6):652-658.

Related calculators